Adipose-derived stem cell exosomes for treatment of dupilumab-related facial redness in patients with atopic dermatitis

References

• Simpson EL, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375(24):1–8.
   PubMed Web of Science ®Google Scholar
• de Bruin-Weller M, Thaci D, Smith CH, et al. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin a or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFE). Br J Dermatol. 2018;178(5):1083–1101.
   PubMed Web of Science ®Google Scholar
• Blauvelt A, de Bruin-Weller M, Gooderham M, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017;389​(10086):2287–2303.
   PubMed Web of Science ®Google Scholar
• Jang DH, Heo SJ, Jung HJ, et al. Retrospective study of dupilumab treatment for moderate to severe atopic dermatitis in Korea: efficacy and safety of dupilumab in real-world practice. J Clin Med. 2020;9(6):1982.
   Web of Science ®Google Scholar
• Seok SH, An JH, Shin JU, et al. Facial redness in atopic dermatitis patients treated with dupilumab: a case series. Allergy Asthma Immunol Res. 2020;12(6):1063–1065.
   PubMed Web of Science ®Google Scholar
• Soria A, Du-Thanh A, Seneschal J, et al. Development or exacerbation of head and neck dermatitis in patients treated for atopic dermatitis with dupilumab. JAMA Dermatol. 2019;155(11):1312–1315.
   PubMed Web of Science ®Google Scholar
• Lee DH, Ko HC, Na CH, et al. Real-World experience of Long-Term dupilumab treatment for atopic dermatitis in Korea. Ann Dermatol. 2022;34(2):157–160.
   PubMed Web of Science ®Google Scholar
• Kozera E, Flora A, Stewart T, et al. Dupilumab-associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib, with malassezia-specific immunoglobulin E levels mirroring clinical response. J Am Acad Dermatol. 2023;88(1):255–257.
   PubMed Web of Science ®Google Scholar
• Ferrucci S, Angileri L, Tavecchio S, et al. Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease. J Dermatolog Treat. 2022;33(5):2587–2592.
   PubMed Web of Science ®Google Scholar
• Kee LT, Ng CY, Al-Masawa ME, et al. Extracellular vesicles in facial aesthetics: a review. Int J Mol Sci. 2022;23(12):6742.
   Web of Science ®Google Scholar
• Weiliang Z, Lili G. Research advances in the application of adipose-derived stem cells derived exosomes in cutaneous wound healing. Ann Dermatol. 2021;33(4):309–317.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yin Y, Lai RC, et al. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev. 2014;23(11):1233–1244.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yeo RWY, Lai RC, et al. Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway. Cytotherapy. 2018;20(5):687–696.
   PubMed Web of Science ®Google Scholar
• Cho BS, Kim JO, Ha DH, et al. Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis. Stem Cell Res Ther. 2018;9(1):187.
   PubMedGoogle Scholar
• Jang B, Chung H, Jung H, et al. Extracellular vesicles from Korean codium fragile and Sargassum fusiforme negatively regulate melanin synthesis. Mol Cells. 2021;44(10):736–745.
   PubMed Web of Science ®Google Scholar
• Narauskaite D, Vydmantaite G, Rusteikaite J, et al. Extracellular vesicles in skin wound healing. Pharmaceuticals. 2021;14(8):811.
   Web of Science ®Google Scholar
• Shen Y, Xu G, Huang H, et al. Sequential release of small extracellular vesicles from bilayered thiolated alginate/polyethylene glycol diacrylate hydrogels for scarless wound healing. ACS Nano. 2021;15(4):6352–6368.
   PubMed Web of Science ®Google Scholar
• Shin KO, Ha DH, Kim JO, et al. Exosomes from human adipose Tissue-Derived mesenchymal stem cells promote epidermal barrier repair by inducing de novo synthesis of ceramides in atopic dermatitis. Cells. 2020;9(3):680.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhao Y, Zhang Q. Human mesenchymal stem cell-derived exosomes accelerate wound healing of mice eczema. J Dermatolog Treat. 2022;33(3):1401–1405.
   PubMed Web of Science ®Google Scholar
• Wang WM, Wu C, Jin HZ. Exosomes in chronic inflammatory skin diseases and skin tumors. Exp Dermatol. 2019;28(3):213–218.
   PubMed Web of Science ®Google Scholar
• Xu P, Xin Y, Zhang Z, et al. Extracellular vesicles from adipose-derived stem cells ameliorate ultraviolet B-induced skin photoaging by attenuating reactive oxygen species production and inflammation. Stem Cell Res Ther. 2020;11(1):264.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yan J, Li Z, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate psoriasis-like skin inflammation. J Interferon Cytokine Res. 2022;42(1):8–18.
   PubMed Web of Science ®Google Scholar
• Zhang B, Lai RC, Sim WK, et al. Topical application of mesenchymal stem cell exosomes alleviates the imiquimod induced psoriasis-like inflammation. Int J Mol Sci. 2021;22(2):720.
   Web of Science ®Google Scholar
• Park KY, Han HS, Park JW, et al. Exosomes derived from human adipose tissue-derived mesenchymal stem cells for the treatment of dupilumab-related facial redness in patients with atopic dermatitis: a report of two cases. J Cosmet Dermatol. 2022;21(2):844–849.
   PubMed Web of Science ®Google Scholar
• Kwon HH, Yang SH, Lee J, et al. Combination treatment with human adipose tissue stem cell-derived exosomes and fractional CO2 laser for acne scars: a 12-week prospective, double-blind, randomized, split-face study. Acta Derm Venereol. 2020;100(18):adv00310.
   PubMedGoogle Scholar
• Ahn J, Lee DH, Na CH, et al. Facial erythema in patients with atopic dermatitis treated with dupilumab – a descriptive study of morphology and aetiology. Acad Dermatol Venereol. 2022;36(11):2140–2152.
   PubMed Web of Science ®Google Scholar
• de Beer FSA, Bakker DS, Haeck I, et al. Dupilumab facial redness: positive effect of itraconazole. JAAD Case Rep. 2019;5(10):888–891.
   PubMedGoogle Scholar
• Nakanishi M, Tamagawa-Mineoka R, Arakawa Y, et al. Dupilumab-resistant facial erythema – dermoscopic, histological and clinical findings of three patients. Allergol Int. 2021;70(1):156–158.
   PubMed Web of Science ®Google Scholar
• de Wijs LEM, Nguyen NT, Kunkeler ACM, et al. Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series. Br J Dermatol. 2020;183(4):745–749.
   PubMed Web of Science ®Google Scholar
• Jo CE, Finstad A, Georgakopoulos JR, et al. Facial and neck erythema associated with dupilumab treatment: a systematic review. J Am Acad Dermatol. 2021;84(5):1339–1347.
   PubMed Web of Science ®Google Scholar
• Moghadasi S, Elveny M, Rahman HS, et al. A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine. J Transl Med. 2021;19(1):302.
   PubMed Web of Science ®Google Scholar
• Solimani F, Meier K, Ghoreschi K. Emerging topical and systemic JAK inhibitors in dermatology. Front Immunol. 2019;10:2847.
   PubMed Web of Science ®Google Scholar
• Jensen LE. Targeting the IL-1 family members in skin inflammation. Curr Opin Investig Drugs. 2010;11(11):1211–1220.
   PubMedGoogle Scholar
• Martin P, Goldstein JD, Mermoud L, et al. IL-1 family antagonists in mouse and human skin inflammation. Front Immunol. 2021;12:652846.
   PubMed Web of Science ®Google Scholar
• Cohen I, Rider P, Carmi Y, et al. Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc Natl Acad Sci USA. 2010;107(6):2574–2579.
   PubMed Web of Science ®Google Scholar
• Alkharsah KR. VEGF upregulation in viral infections and its possible therapeutic implications. Int J Mol Sci. 2018;19(6):1642.
   PubMed Web of Science ®Google Scholar
• Hu L, Wang J, Zhou X, et al. Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci Rep. 2016;6:32993.
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang M, Gong A, et al. HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells. 2015;33(7):2158–2168.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen C, Hu B, et al. Exosomes derived from human endothelial progenitor cells accelerate cutaneous wound healing by promoting angiogenesis through Erk1/2 signaling. Int J Biol Sci. 2016;12(12):1472–1487.
   PubMed Web of Science ®Google Scholar
• Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366(9498):1736–1743.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Choi MJ, Bak DH, et al. Topical administration of EGF suppresses immune response and protects skin barrier in DNCB-induced atopic dermatitis in NC/nga mice. Sci Rep. 2018;8(1):11895.
   PubMedGoogle Scholar
• Debinska A. New treatments for atopic dermatitis targeting skin barrier repair via the regulation of FLG expression. J Clin Med. 2021;10(11):2506.
   PubMed Web of Science ®Google Scholar
• Kim JH, Bae HC, Ko NY, et al. Thymic stromal lymphopoietin downregulates filaggrin expression by signal transducer and activator of transcription 3 (STAT3) and extracellular signal-regulated kinase (ERK) phosphorylation in keratinocytes. J Allergy Clin Immunol. 2015;136(1):205–208 e9.
   PubMed Web of Science ®Google Scholar
• Wilson SR, The L, Batia LM, et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell. 2013;155(2):285–295.
   PubMed Web of Science ®Google Scholar
• Ziegler SF. Thymic stromal lymphopoietin and allergic disease. J Allergy Clin Immunol. 2012;130(4):845–852.
   PubMed Web of Science ®Google Scholar
• Ahn J, Choi Y, Simpson EL. Therapeutic new era for atopic dermatitis: part 1. Biologics. Ann Dermatol. 2021;33(1):1–10.
   PubMed Web of Science ®Google Scholar